Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
antisense
Press Release
Aug 29, 2018
First Patient Dosed in Phase II Clinical Trial in Duchenne Muscular Dystrophy
Read More
Press Release
May 23, 2018
ATL1103 Phase II Trial Results Published in the European Journal of Endocrinology
Read More
Press Release
Feb 28, 2018
Approval Received for Phase II Trial of ATL1102 in Duchenne Muscular Dystrophy
Read More
First
Prev
1
Next
Last